隆基绿能：控股股东李振国解除质押1.55亿股-36氪

Roche to Pay Nurix as Much as $2.3 Billion in Cancer Deal

(Bloomberg) -- Roche Holding AG agreed to pay Nurix Therapeutics Inc. as much as $2.3 billion for rights to an experimental blood-cancer drug, betting it can help patients whose disease stops responding to existing…